A detailed history of Baker Avenue Asset Management, LP transactions in Natera, Inc. stock. As of the latest transaction made, Baker Avenue Asset Management, LP holds 1,811 shares of NTRA stock, worth $304,628. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,811
Holding current value
$304,628
% of portfolio
0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$97.75 - $129.67 $177,025 - $234,832
1,811 New
1,811 $230,000
Q4 2022

Feb 13, 2023

BUY
$34.17 - $47.91 $854 - $1,197
25 New
25 $1,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Baker Avenue Asset Management, LP Portfolio

Follow Baker Avenue Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Avenue Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Baker Avenue Asset Management, LP with notifications on news.